A detailed history of Coston, Mc Isaac & Partners transactions in Novartis Ag stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 150 shares of NVS stock, worth $14,752. This represents 0.01% of its overall portfolio holdings.

Number of Shares
150
Previous 150 -0.0%
Holding current value
$14,752
Previous $15,000 13.33%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$75.55 - $92.52 $7,555 - $9,252
100 Added 200.0%
150 $13,000
Q2 2022

Sep 21, 2022

BUY
$80.52 - $93.75 $4,026 - $4,687
50 New
50 $4,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Coston, Mc Isaac & Partners Portfolio

Follow Coston, Mc Isaac & Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coston, Mc Isaac & Partners, based on Form 13F filings with the SEC.

News

Stay updated on Coston, Mc Isaac & Partners with notifications on news.